Airway Effects of Tiotropium in Patients With COPD

Conditions:   COPD;   LUNG DISEASES, OBSTRUCTIVE
Interventions:   Device: Handihaler-Tiotropium 18 mcg untrained;   Device: Handihaler-Tiotropium 18 mcg trained;   Device: Respimat-Tiotropium 5 mcg trained
Sponsors:   Imperial College London;   Boehringer Ingelheim
Not yet recruiting – verified October 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.